GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Centene Corporation (CNC) [hlAlert]

Rating:
Outperform
CNC
up 119.93 %

Centene Corporation (CNC) rated Outperform by Leerink Swann

Posted on: Tuesday,  Nov 19, 2013  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Centene Corporation (NYSE: CNC) on 11/19/2013, when the stock price was $28.75. Since
then, Centene Corporation has gained 119.93% as of 01/21/2016's recent price of $63.23.
If you would have followed this Leerink Swann 's recommendation on CNC, you would have gained 119.93% of your investment in 793 days.

Centene Corporation is a multi-line healthcare enterprise operating primarily in two segments: Medicaid Managed Care and Specialty Services. The Company?s Medicaid Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through government subsidized programs, including Medicaid, the State Children?s Health Insurance Program (SCHIP), Foster Care, Medicare Special Needs Plans and Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD). The Company?s Specialty Services segment provides specialty services, including behavioral health, individual health insurance, life and health management, long-term care programs, managed vision, nurse triage, and pharmacy benefits management to state programs, healthcare organizations, employer groups and other commercial organizations, as well as to its subsidiaries.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/19/2013 8:25 AM Buy
None
28.75
as of 12/13/2013
1 Week down  -4.33 %
1 Month up  0.13 %
3 Months   
1 YTD up  0.13 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy